ATS Medical shareholders approve $370M sale to Medtronic
The shareholders of cardiovascular technology firm ATS Medical (NASDAQ: ATSI) voted in favor of the company’s $370 million sale to neighboring device giant Medtronic Inc. (NYSE: MDT). About 79 percent of the company’s outstanding shares were voted, with about 95 percent of those in approval of the $4-per-share deal, according to a statement from Plymouth, […]